Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
SoftVest, LP purchased 68,467 units of Cross Timbers Royalty Trust (NYSE: CRT) on March 27, 2026, paying a weighted average price of $10.24 per unit for a total of $701,102. Following the acquisition the firm directly holds 697,851 units. The move coincides with a recent 16% one-week gain in CRT shares and a near 40% year-to-date rise, though third…
Karen A. Foster, Chief Quality and Operations at BioLife Solutions Inc (NASDAQ: BLFS), sold 2,577 shares on March 23, 2026, under a Rule 10b5-1 trading plan. The transaction, executed at a weighted average price of $19.17, totaled $49,401 and leaves Foster with 108,758 shares held directly. The sale occurs while BLFS is trading close to its 52-week…
Russian stocks ended lower after the close on Tuesday, with the MOEX Russia Index dropping 0.84% to a new one-month low. Losses originated in the Oil & Gas, Mining and Manufacturing sectors. Market breadth was negative, implied volatility eased, and commodities showed mixed performance as gold rallied and crude futures diverged.
Asana Inc.'s Chief Financial Officer, Megji Aziz, sold 30,650 Class A shares on March 27, 2026, receiving $6.1033 per share for a total of $187,066. The transaction was carried out under a pre-established Rule 10b5-1 plan and follows recent company results and multiple analyst price-target reductions. Aziz continues to hold 224,549 shares after the…
Global equity markets finished the first quarter with a dramatic rally as signs of potential easing in the Middle East conflict drove risk appetite. The upside came despite fresh data showing a fall in U.S. job openings and hiring. Energy markets, megacap performance and pronounced volatility marked a quarter with wide swings across regions and ass…
Rapport Therapeutics Chief Operating Officer Cheryl Gault sold 10,000 shares of the company's common stock on March 30, 2026, in two transactions totaling $281,857 under a Rule 10b5-1 trading plan. The company recently reported fiscal 2025 results and Phase IIa data for RAP-219 in focal seizures, and plans to begin two Phase 3 studies in the second…
Brazil's central bank significantly increased its allocation to gold in 2025, raising the metal's share of foreign exchange reserves to 7.19% from 3.55% a year earlier. The dollar's share dropped to a record low of 72.00%. Total reserves reached $358.23 billion at year-end, with returns up 9.18% driven mainly by interest income and currency movemen…
Director Lu Hongbo bought 75,000 shares of Zenas BioPharma, Inc. (NASDAQ: ZBIO) on March 31, 2026, at $20.00 per share, a $1.5 million purchase executed through an underwritten public offering. The acquisition increases Lu's indirect holdings to 422,968 shares. The company concurrently announced a $200 million convertible note offering and a 5 mill…
SCHG (Schwab U.S. Large-Cap Growth ETF) offers concentrated exposure to high-quality U.S. growth names at a valuation that still leaves room for upside. With a $48.3B market cap, a 10-year track record of outperformance, and a current price sitting below key moving averages, this trade idea targets a recovery to near-term highs while limiting downs…
Macy's Executive Vice President and Chief Human Resources Officer Danielle L. Kirgan sold 5,161 shares of Macy's common stock on March 30, 2026 for $91,515 after exercising 11,256 restricted stock units on March 28. The stock trades at $18.10, and third-party analysis places the company near a fair value of $17.74 with a low P/E of 7.8. Macy's repo…
HMH Holding Inc. set its initial public offering price at $20 per share for 10.52 million Class A shares, targeting gross proceeds of $210.4 million. Underwriters have a 30-day option to buy an additional 1.58 million shares at the IPO price, which if exercised would lift total proceeds to about $242 million. The company expects trading to begin on…
Rezolute Chief Financial Officer Daron Evans purchased 10,000 common shares on March 30, 2026, acquiring stock worth $28,500 at $2.85 per share, increasing his direct holdings to 414,462 shares. The buy comes amid a roughly 70% six-month decline in the stock and ongoing regulatory engagement with the FDA over the company’s ersodetug program for con…
Beyond Meat reported a steeper-than-expected operating loss and quarterly revenue that missed analyst estimates as demand for higher-priced processed plant-based products remained weak. The company also disclosed delays to reporting driven by identified material weaknesses in inventory accounting and said it cannot yet estimate when its annual repo…
A Reuters/Ipsos survey conducted over a recent weekend found that roughly 66% of Americans want the United States to seek a rapid end to its involvement in the Iran war even if that means not achieving the administration's stated goals. The poll also reveals broad disapproval of U.S. military strikes on Iran, concerns about rising gasoline costs, a…
KBR trades at a low-teens P/E and sub-9x EV/EBITDA while winning long-term maintenance and catalyst contracts and investing in AI-driven offerings. We think near-term technical weakness is priced in and a disciplined entry around $36.50 with a $52 target over 180 trading days offers a favorable reward-to-risk.
Caliber, a Nasdaq-listed diversified real estate and digital asset management company, announced the nomination of J. Alan Reid, Jr. to its board of directors as part of a planned transition. Two current directors, Dan Hansen and Michael Trzupek, will not seek re-election at the May 14, 2026 annual meeting as they focus on expanded roles elsewhere.…
ORIC Pharmaceuticals' stock dropped 27% after the company named 400 mg once daily as the recommended Phase 3 dose of rinzimetostat in combination with darolutamide for the Himalayas-1 registrational trial in post-abiraterone metastatic castration-resistant prostate cancer. The choice followed dose-optimization findings showing comparable efficacy b…
The Federal Reserve Bank of New York has appointed Citigroup CEO Jane Fraser to the Federal Advisory Council for a one-year term that began in January. The council, which offers industry perspective to the Fed's Board of Governors, includes one banking representative from each of the 12 Federal Reserve districts and typically meets quarterly in Was…
S&P Global Ratings upgraded the Cook Islands' long-term sovereign credit rating to BB- from B+ late on Tuesday, citing a tourism-led economic rebound and fiscal restraint that have strengthened public finances. The agency assigned a stable outlook, maintained the short-term sovereign rating at B and kept the transfer and convertibility assessment a…
A federal judge in Manhattan has permitted former Twitter investors to proceed with a class action alleging Elon Musk delayed disclosing his initial stake in the company, potentially exposing him to larger damages. Plaintiffs contend Musk violated SEC timing rules by failing to reveal a 5% ownership threshold on March 24, 2022 and instead disclosed…
USA Rare Earth (USAR) is a politically favored, capital-rich developer of domestic rare-earth magnet supply chains. The stock is volatile and structurally overvalued on typical metrics, but recent funding news and operational milestones create recurring momentum windows. This trade idea proposes a disciplined, mid-term long to capture a technical b…
Martine Rothblatt, chairperson and CEO of United Therapeutics (UTHR), sold $5.6 million of company stock on March 30, 2026 under a pre-arranged 10b5-1 trading plan and exercised options to acquire additional shares the same day. The transactions come amid a wave of analyst updates following positive Phase 3 TETON-1 results for the company’s Tyvaso …
Syntec Optics Holdings, Inc. announced strong financial results for Q4 and full year 2025 driven by operational efficiency improvements, including a doubling of gross margin in Q4 to 24% and a 36% increase in adjusted EBITDA for the full year. Despite a slight decline in net sales from 2024, gross profit and margin expansion, along with reduced SG&…
Epsilon Energy Ltd. CEO Jason Stabell bought 20,000 common shares between March 27 and March 31, 2026, spending $124,180 across three transactions reported on a Form 4 filing. The purchases come after a quarterly earnings beat and amid a substantial year-to-date share-price gain; the stock traded at $6.16 at the close, down 0.65%.
Macy’s Chairman and CEO Antony Spring disposed of 27,451 shares of common stock on March 30, 2026, generating roughly $486,799 at prices between $17.5450 and $17.8850. A Form 4 filing shows Spring also exercised options to acquire 53,152 shares on March 28, 2026, shares that were obtained via conversion of restricted stock units. The insider moves …
